STTK Stock Price, Shattuck Labs Inc Quote, Chart

Market Summary

USD7.90+0.06

Delayed

0.77%

STTK Stock Price

View Fullscreen

STTK RSI Chart

STTK Valuation

Market Cap

375.7M

Price/Earnings (Trailing)

-4.42

Price/Sales (Trailing)

138.36

Price/Free Cashflow

-5.27

STTK Price/Sales (Trailing)

STTK Profitability

Return on Equity

-66.05%

Return on Assets

-58.14%

Free Cashflow Yield

-18.97%

STTK Fundamentals

STTK Revenue

Revenue (TTM)

2.7M

Rev. Growth (Yr)

1.9K%

Rev. Growth (Qtr)

56.16%

STTK Earnings

Earnings (TTM)

-85.1M

Earnings Growth (Yr)

10.71%

Earnings Growth (Qtr)

-4.62%

Breaking Down STTK Revenue

Last 7 days

-24.2%

Last 30 days

-21.2%

Last 90 days

-17.6%

Trailing 12 Months

194.8%

How does STTK drawdown profile look like?

STTK Financial Health

Current Ratio

9.15

STTK Investor Care

Shares Dilution (1Y)

11.99%

Diluted EPS (TTM)

-1.93

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.7M	0	0	0
2023	755.5K	859.0K	1.3M	1.7M
2022	0	20.2M	10.4M	652.0K
2021	9.2M	0	7.9M	30.0M
2020	9.9M	9.9M	9.9M	9.9M
2019	0	0	0	9.9M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Shattuck Labs Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Mar 28, 2024	redmile group, llc	sold	-	-	-4,425	-
Mar 06, 2024	stout stephen	sold	-168,522	10.53	-16,004	see remarks
Mar 06, 2024	stout stephen	acquired	39,380	3.54489	11,109	see remarks
Jan 30, 2024	pandite arundathy n.	sold (taxes)	-29,170	9.99	-2,920	chief medical officer
Jan 30, 2024	stout stephen	sold (taxes)	-5,924	9.99	-593	see remarks
Jan 30, 2024	shukla abhinav a.	sold (taxes)	-22,877	9.99	-2,290	chief technical officer
Jan 30, 2024	deyoung casi	sold (taxes)	-20,059	9.99	-2,008	chief business officer
Jan 10, 2024	pandite arundathy n.	sold (taxes)	-30,138	10.09	-2,987	chief medical officer
Jan 10, 2024	neill andrew r	acquired	-	-	56,500	chief financial officer
Jan 10, 2024	neill andrew r	sold (taxes)	-24,922	10.09	-2,470	chief financial officer

Which funds bought or sold STTK recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	JANE STREET GROUP, LLC	added	1,150	3,109,770	3,321,680	-%
May 15, 2024	BRIDGEWAY CAPITAL MANAGEMENT, LLC	reduced	-25.55	-23,751	333,462	0.01%
May 15, 2024	TWO SIGMA ADVISERS, LP	new	-	288,762	288,762	-%
May 15, 2024	ADAGE CAPITAL PARTNERS GP, L.L.C.	added	35.22	8,691,010	21,187,800	0.04%
May 15, 2024	TWO SIGMA INVESTMENTS, LP	new	-	1,110,160	1,110,160	-%
May 15, 2024	MILLENNIUM MANAGEMENT LLC	added	5,652	5,398,810	5,474,710	-%
May 15, 2024	MARSHALL WACE, LLP	new	-	692,806	692,806	-%
May 15, 2024	PRELUDE CAPITAL MANAGEMENT, LLC	sold off	-100	-377,890	-	-%
May 15, 2024	SYMMETRY PEAK MANAGEMENT LLC	sold off	-100	-10,695	-	-%
May 15, 2024	Laurion Capital Management LP	unchanged	-	1,196,480	5,909,680	0.05%

Are Funds Buying or Selling STTK?

Are funds buying STTK calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own STTK

No. of Funds

Unveiling Shattuck Labs Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 09, 2024	fmr llc	-	0	SC 13G/A
Jan 29, 2024	adage capital partners gp, l.l.c.	5.47%	2,577,705	SC 13G
Jan 02, 2024	prosight management, lp	5.9%	2,782,797	SC 13G
Dec 26, 2023	redmile group, llc	12.0%	5,664,892	SC 13D/A
Feb 09, 2023	fmr llc	-	0	SC 13G/A
Dec 09, 2022	hornblower josiah	7.0%	2,977,627	SC 13D/A
Jun 09, 2022	blackrock inc.	4.97%	2,110,075	SC 13G
Feb 14, 2022	ecor1 capital, llc	0%	0	SC 13G/A
Feb 09, 2022	fmr llc	-	0	SC 13G/A
Feb 04, 2022	blackrock inc.	5.2%	2,209,819	SC 13G

Recent SEC filings of Shattuck Labs Inc

View All Filings

Date Filed	Form Type	Document
May 14, 2024	4	Insider Trading
May 02, 2024	10-Q	Quarterly Report
May 02, 2024	8-K	Current Report
Apr 23, 2024	ARS	ARS
Apr 23, 2024	DEF 14A	DEF 14A
Apr 23, 2024	DEFA14A	DEFA14A
Apr 01, 2024	4	Insider Trading
Mar 08, 2024	4	Insider Trading
Mar 08, 2024	3	Insider Trading
Mar 08, 2024	3	Insider Trading

Peers (Alternatives to Shattuck Labs Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
MRNA	50.9B	6.8B	28.49%	6.05%	-8.53	7.44	-64.45%	-224.75%
HILS	22.5B	216.3K	-0.77%	465779.94%	-2.5K	104.0K	-	-8.13%
ALNY	18.9B	2.0B	2.79%	-21.33%	-56.9	9.43	75.20%	68.82%
BMRN	14.7B	2.5B	-14.30%	-15.94%	71.65	5.96	13.74%	186.89%
INCY	12.8B	3.8B	8.33%	-10.25%	17.2	3.4	8.58%	129.81%
MID-CAP
BBIO	5.6B	107.9M	20.58%	115.45%	-10.31	48.09	54.84%	-28.31%
APLS	5.0B	524.1M	-13.99%	-52.79%	-12.02	9.57	394.93%	39.61%
AXSM	3.6B	251.0M	9.96%	-0.29%	-12.28	14.5	73.58%	-86.73%
ARWR	3.1B	240.7M	9.94%	-31.73%	-6.53	12.77	-1.03%	-213.43%
ACAD	2.4B	813.8M	-14.08%	-36.34%	-1.4K	3	56.43%	98.83%
SMALL-CAP
CPRX	1.9B	411.3M	3.06%	35.16%	29.91	4.73	60.38%	-34.49%
NVAX	1.8B	996.6M	233.93%	75.07%	-4.57	1.83	-26.66%	65.49%
CRBP	480.9M	881.7K	21.10%	351.81%	-14.25	481.06	-77.61%	33.36%
INO	310.9M	4.9M	8.40%	53.85%	-2.49	63.89	-54.97%	48.23%
IBIO	17.1M	2.1M	4.76%	108.64%	-0.74	7.61	-13.45%	69.54%

Shattuck Labs Inc News

Latest updates

Shattuck Labs Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																	(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2021Q4	2021Q3	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Revenue	56.2%	1,115	714	686	200	57.00	390	212	775	1,337	1,900	2,270	1,342	2,435	3,181	2,976	2,380	1,784
Operating Expenses	7.6%	21,159	19,665	29,284	22,947	21,718	26,666	25,441	27,708	20,832	19,480	14,693	13,353	14,274	9,501	9,737	-	9,311
S&GA Expenses	-100.0%	-	4,438	5,073	4,742	5,051	4,779	6,579	4,745	4,625	4,343	4,356	3,566	2,470	1,746	1,600	-	1,366
R&D Expenses	6.8%	16,264	15,227	24,211	18,205	16,667	21,887	18,862	22,963	16,207	15,137	10,337	9,787	11,804	7,755	8,137	-	7,945
Net Income	-4.6%	-18,504	-17,687	-27,541	-21,346	-20,724	-25,411	-24,635	-27,371	7,847	-17,410	-11,813	-12,012	-11,829	-6,208	-6,554	-7,369	-7,279
Net Income Margin	40.5%	-31.34*	-52.68*	-71.28*	-107.24*	-129.90*	-156.36*	-6.58*	-3.04*	-1.50*	-8.16*	-4.54*	-	-	-	-	-	-
Free Cashflow	16.9%	-16,161	-19,436	-16,751	-18,912	-26,536	-24,534	-28,814	-23,999	-20,707	-13,956	-13,706	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2019Q4
Assets	-8.3%	146	160	130	155	178	205	223	251	270	299	311	324	337	349	145	45.00
Current Assets	-8.5%	131	143	113	136	158	185	202	229	255	288	302	316	331	346	142	42.00
Cash Equivalents	-39.5%	76.00	126	41.00	72.00	66.00	47.00	40.00	38.00	51.00	92.00	85.00	86.00	85.00	158	129	7.00
Net PPE	-7.1%	13.00	14.00	15.00	16.00	17.00	18.00	18.00	19.00	12.00	10.00	9.00	8.00	5.00	3.00	3.00	2.00
Liabilities	17.9%	18.00	15.00	18.00	17.00	20.00	29.00	24.00	29.00	22.00	27.00	49.00	47.00	38.00	39.00	37.00	30.00
Current Liabilities	25.1%	14.00	11.00	14.00	13.00	16.00	25.00	19.00	24.00	17.00	25.00	20.00	15.00	18.00	17.00	16.00	20.00
Shareholder's Equity	-11.0%	129	145	113	138	158	176	199	223	249	272	261	277	299	310	-	-
Retained Earnings	-6.0%	-324	-306	-288	-261	-239	-219	-193	-169	-141	-117	-124	-107	-83.90	-72.09	-60.10	-35.49
Additional Paid-In Capital	0.6%	454	451	401	400	398	396	394	393	391	389	388	386	383	382	2.00	1.00
Shares Outstanding	0.6%	48.00	47.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	42.00	-	-	-
Float	-	-	-	-	86.00	-	-	-	111	-	-	-	690	-	-	554	-

Cashflow (Last 12 Months)

(In Thousands)

(*) denotes actual numbers (not divided by Thousands)
Cashflow (Quarterly)																			(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3
Cashflow From Operations	16.8%	-16,161	-19,419	-16,732	-18,616	-26,461	-23,841	-28,064	-16,316	-26,277	-18,717	-12,992	-14,339	-11,068	-14,043	-11,348	2,185	-10,453	-	-
Share Based Compensation	50.9%	2,475	1,640	1,764	1,852	1,683	1,693	1,723	1,533	1,513	1,216	1,344	1,727	1,180	637	312	143	174	-	-
Cashflow From Investing	-159.6%	-33,276	55,851	-14,550	24,433	45,125	31,462	29,925	3,433	-15,382	25,601	11,240	14,843	-62,127	-171,488	9,987	8,481	6,698	-	-
Cashflow From Financing	-100.4%	-184	48,562	21.00	33.00	-	-	27.00	10.00	134	290	352	1,256	31.00	214,829	-1,083	82,687	34,433	-	-

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

STTK Income Statement

2024-03-31

CONDENSED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Collaboration revenue	$ 1,115	$ 57
Revenue from Contract with Customer, Product and Service [Extensible List]	License	License
Operating expenses:
Research and development	$ 16,264	$ 16,667
General and administrative	4,895	5,051
Expense from operations	21,159	21,718
Loss from operations	(20,044)	(21,661)
Other income	1,540	937
Net loss	(18,504)	(20,724)
Unrealized (loss) gain on investments	(18)	538
Comprehensive loss	$ (18,522)	$ (20,186)
Net loss per share – basic (in dollars per share)	$ (0.37)	$ (0.49)
Net loss per share – diluted (in dollars per share)	$ (0.37)	$ (0.49)
Weighted-average shares outstanding – basic (in shares)	50,566,394	42,439,204
Weighted-average shares outstanding – diluted (in shares)	50,566,394	42,439,204

STTK Balance Sheet

2024-03-31

CONDENSED BALANCE SHEETS - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets:
Cash and cash equivalents	$ 76,005	$ 125,626
Investments	38,628	4,999
Prepaid expenses and other current assets	16,443	12,595
Total current assets	131,076	143,220
Property and equipment, net	12,830	13,804
Other assets	2,429	2,540
Total assets	146,335	159,564
Current liabilities:
Accounts payable	2,154	1,587
Accrued expenses and other current liabilities	7,569	9,523
Contract with Customer, Liability, Current	4,606	343
Total current liabilities	14,329	11,453
Non-current operating lease liabilities	3,193	3,406
Total liabilities	17,522	14,859
Commitments and contingencies (Note 5)
Stockholders’ equity:
Common stock, $0.0001 par value: 300,000,000 shares authorized; 47,519,219 shares issued and outstanding at March 31, 2024 and 47,260,108 shares issued and outstanding at December 31, 2023	5	5
Additional paid-in capital	453,636	451,006
Accumulated other comprehensive (loss) income	(14)	4
Accumulated deficit	(324,814)	(306,310)
Total stockholders’ equity	128,813	144,705
Total liabilities and stockholders’ equity	$ 146,335	$ 159,564

About Shattuck Labs Inc

Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. The company was incorporated in 2016 and is headquartered in Austin, Texas.

CEO	Dr. Taylor H. Schreiber M.D., Ph.D.
WEBSITE	shattucklabs.com
INDUSTRY	Biotechnology
EMPLOYEES	105

Shattuck Labs Inc Frequently Asked Questions

What is the ticker symbol for Shattuck Labs Inc? What does STTK stand for in stocks?

STTK is the stock ticker symbol of Shattuck Labs Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Shattuck Labs Inc (STTK)?

As of Fri May 17 2024, market cap of Shattuck Labs Inc is 375.65 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STTK stock?

You can check STTK's fair value in chart for subscribers.

What is the fair value of STTK stock?

You can check STTK's fair value in chart for subscribers. The fair value of Shattuck Labs Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Shattuck Labs Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STTK so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Shattuck Labs Inc a good stock to buy?

The fair value guage provides a quick view whether STTK is over valued or under valued. Whether Shattuck Labs Inc is cheap or expensive depends on the assumptions which impact Shattuck Labs Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STTK.

What is Shattuck Labs Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, STTK's PE ratio (Price to Earnings) is -4.42 and Price to Sales (PS) ratio is 138.36. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STTK PE ratio will change depending on the future growth rate expectations of investors.